Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

RATIONALE The Severe Asthma Research Program cohort includes subjects with persistent asthma who have undergone detailed phenotypic characterization. Previous univariate methods compared features of mild, moderate, and severe asthma. OBJECTIVES To identify novel asthma phenotypes using an unsupervised hierarchical cluster analysis. METHODS Reduction of the initial 628 variables to 34 core variables was achieved by elimination of redundant data and transformation of categorical variables into ranked ordinal composite variables. Cluster analysis was performed on 726 subjects. MEASUREMENTS AND MAIN RESULTS Five groups were identified. Subjects in Cluster 1 (n = 110) have early onset atopic asthma with normal lung function treated with two or fewer controller medications (82%) and minimal health care utilization. Cluster 2 (n = 321) consists of subjects with early-onset atopic asthma and preserved lung function but increased medication requirements (29% on three or more medications) and health care utilization. Cluster 3 (n = 59) is a unique group of mostly older obese women with late-onset nonatopic asthma, moderate reductions in FEV(1), and frequent oral corticosteroid use to manage exacerbations. Subjects in Clusters 4 (n = 120) and 5 (n = 116) have severe airflow obstruction with bronchodilator responsiveness but differ in to their ability to attain normal lung function, age of asthma onset, atopic status, and use of oral corticosteroids. CONCLUSIONS Five distinct clinical phenotypes of asthma have been identified using unsupervised hierarchical cluster analysis. All clusters contain subjects who meet the American Thoracic Society definition of severe asthma, which supports clinical heterogeneity in asthma and the need for new approaches for the classification of disease severity in asthma.

[1]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[2]  D. Postma,et al.  Adult patients may outgrow their asthma: a 25-year follow-up study. , 1997, American journal of respiratory and critical care medicine.

[3]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[4]  D. Postma,et al.  Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. , 1998, American journal of respiratory and critical care medicine.

[5]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[6]  R. Duranti,et al.  Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. , 1999, The Journal of allergy and clinical immunology.

[7]  E. Silverman,et al.  Application of an algorithm for the diagnosis of asthma in Chinese families: limitations and alternatives for the phenotypic assessment of asthma in family-based genetic studies. , 2000, American journal of respiratory and critical care medicine.

[8]  W. Busse,et al.  Pathophysiology of severe asthma. , 2000, The Journal of allergy and clinical immunology.

[9]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[10]  Barrett T. Kitch,et al.  FEV(1) is associated with risk of asthma attacks in a pediatric population. , 2001, The Journal of allergy and clinical immunology.

[11]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.

[12]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[13]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[14]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[15]  E. Gelfand,et al.  A comparison of the clinical characteristics of children and adults with severe asthma. , 2003, Chest.

[16]  P. Barnes,et al.  Parameters associated with persistent airflow obstruction in chronic severe asthma , 2004, European Respiratory Journal.

[17]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[18]  S. Wenzel,et al.  Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. , 2004, The Journal of allergy and clinical immunology.

[19]  C. Sorkness,et al.  Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. , 2004, American journal of respiratory and critical care medicine.

[20]  Charles A. Johnson,et al.  Severity assessment in asthma: An evolving concept. , 2005, The Journal of allergy and clinical immunology.

[21]  W. Busse,et al.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. , 2005, American journal of respiratory and critical care medicine.

[22]  S. Wenzel,et al.  Severe asthma in adults. , 2005, American journal of respiratory and critical care medicine.

[23]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[24]  S. Wenzel Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[25]  W. Moore,et al.  Severe asthma: an overview. , 2006, The Journal of allergy and clinical immunology.

[26]  S. Erzurum,et al.  Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. , 2006, The Journal of allergy and clinical immunology.

[27]  E. R. Sutherland,et al.  Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. , 2007, American journal of respiratory and critical care medicine.

[28]  I. Pavord,et al.  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.

[29]  D. Curran‐Everett,et al.  IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression , 2007 .

[30]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[31]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[32]  M. Schatz,et al.  The relationship between obesity and asthma severity and control in adults. , 2008, The Journal of allergy and clinical immunology.

[33]  W. Busse,et al.  Alterations of the arginine metabolome in asthma. , 2008, American journal of respiratory and critical care medicine.

[34]  H. Ortega,et al.  Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  Jie Zheng,et al.  Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. , 2008, Chest.

[36]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[37]  J. Cowan,et al.  Dynamic hyperinflation with bronchoconstriction: differences between obese and nonobese women with asthma. , 2008, American journal of respiratory and critical care medicine.

[38]  W. Busse,et al.  Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. , 2008, Journal of applied physiology.

[39]  S. Shore,et al.  Obesity and asthma: possible mechanisms. , 2008, The Journal of allergy and clinical immunology.

[40]  Mario Castro,et al.  Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. , 2008, The Journal of allergy and clinical immunology.

[41]  J. Cowan,et al.  The association between obesity and asthma: interactions between systemic and airway inflammation. , 2008, American journal of respiratory and critical care medicine.

[42]  E. Hoffman,et al.  A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. , 2009, Chest.

[43]  E. Israel,et al.  Noninvasive Markers of Airway Inflammation in Asthma , 2009, Clinical and translational science.

[44]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[45]  E. Gelfand Pediatric asthma: a different disease. , 2009, Proceedings of the American Thoracic Society.

[46]  B. Raby,et al.  Faculty Opinions recommendation of Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010 .

[47]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[48]  I. Pavord Asthma Phenotypes , 2012, Seminars in Respiratory and Critical Care Medicine.